Clinical Trial Update: Ombitasvir/ABT-450 (Paritaprevir)/Ritonavir With Dasabuvir and Ribavirin (RBV) in Treatment Naive and Treatment Experienced Genotype 1a Hepatitis C Virus Infected Adults [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ombitasvir/paritaprevir/ritonavir with dasabuvir and ribavirin in treatment-naive and treatment-experienced adults with Hepatitis C gen…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Dasabuvir (dasabuvir)
• Ombitasvir/Paritaprevir/Ritonavir
• Ribavirin (ribavirin)

Snippet

Sponsor: AbbVie | Conditions: Chronic Hepatitis C, Hepatitis C (HCV) | Phase 3 | Status: COMPLETED | Results posted: 2017-09-05